To the Editor We write regarding the randomized clinical trial conducted by Kronish et al1 that evaluated screening for depression (with and without follow-up treatment) vs no screening on outcomes (quality-adjusted life-years and depression-free days) in patients who survived an acute coronary syndrome (ACS) event. The authors did not observe a difference in outcome between the 3 study groups and concluded that systematic screening may not be justified in this population.1 Their recommendation to reconsider the clinical guidelines that advocate depression screening after cardiovascular events2 seems premature given some of the study’s limitations.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Bush M, Gaynes BN, Smith SC. Additional Considerations for Screening and Treatment of Depression in Patients With Acute Coronary Syndrome. JAMA Intern Med. 2020;180(3):473. doi:10.1001/jamainternmed.2019.7116
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: